Kellerhals Carrard advised Panakes Partners in the financing. Lymphatica Medtech raised a €17.9 million Series B financing round. This round was co-led by TechWald Next S.p.A.,...
Lymphatica Medtech’s €17.9 Million Series B Financing Round
xFarm Technologies’ €36 Million Series C Financing Round
Bär & Karrer serves as legal advisor to xFarm Technologies, while Orrick and Kellerhals Carrard provided assistance to Partech. xFarm Technologies, a European leader in the...
Rhenopharma Group’s Acquisition Of Kenopharma AG
Kellerhals Carrard advised Rhenopharma Group in this acquisition. Rhenopharma Group, a leading service provider in the pharmaceutical sector headquartered in Basel, acquired Konapharma AG, a contract...
WellDev AG’s Acquisition of InnoTix AG From Gobeum Holding AG
Kellerhals Carrard acted as legal advisor to WellDev AG. WellDev AG acquired all shares in InnoTix AG from Gobeum Holding AG. InnoTix AG, a Swiss software...
Orell Füssli’s Acquisition of Majority Stake in hep Verlag
Kellerhals Carrard acted as legal advisor to the buyer. Orell Füssli Group acquired a majority stake in hep Verlag and becomes the largest private Swiss publisher of...